IP Library › Granted Patent US 12,525,327
Granted Patent B1
US 12,525,327 · App. 17/501,532 · Granted Jan 13, 2026

Method, apparatus, and computer program product for providing real-time pricing information

Inventors: Keith Crozier (North Kingstown, RI); Stacy Hopkins (Tucker, GA)
Assignee: McKesson Corporation
G16H20/10G06Q30/0206G06Q30/0629G16H40/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,525,327
App. No.
17/501,532
Filed
Oct 14, 2021
Granted
Jan 13, 2026
Kind
B1
Art Unit
3692
USPC
705/4
Abstract

A method, apparatus and computer program product are provided for providing real-time pricing information to a patient. A patient may submit a prescription inquiry. In response to the prescription inquiry, a cash price inquiry, a prescription benefit inquiry, and a formulary alternative inquiry are generated by a service provider computer accordingly. The various inquiries may be executed by a service provider computer and/or associated systems. Responses may be further processed, such that cash price information, a patient pay amount under a benefit plan, and formulary alternatives and associated costs are included in a prescription inquiry response for provision to a patient or user.

Claims (36)

1 . An apparatus comprising one or more processors and at least one memory including computer program code that when executed by the one or more processors, causes the one or more processors to perform:

storing, in a database, (a) a time threshold, (b) a history of prescription transactions comprising respective medications, prices, and (c) and one or more alternative treatment tables;

receiving from a client device, a prescription inquiry associated with a patient, a pharmacy, and a medication;

generating a cash price inquiry, a prescription benefit coverage inquiry, and a formulary alternative inquiry based on the prescription inquiry;

determining a claims processor computer to which to transmit the prescription benefit coverage inquiry;

transmitting the prescription benefit coverage inquiry to a pharmacy claims processor computer;

monitoring a communication network for receipt of a prescription benefit coverage response associated with the prescription benefit coverage inquiry from the claims processor computer;

determining whether a response from the pharmacy claims processor computer is received within the time threshold;

based on a determination that the response from the pharmacy claims processor computer is received within the time threshold, generating a prescription inquiry response comprising the response from the pharmacy claims processor computer;

based on a determination that the response from the pharmacy claims processor computer is not received within the time threshold, and further based on the stored history of prescription transactions, generating a prescription inquiry response that includes an estimated cost range for the medication;

executing the cash price inquiry, wherein executing the cash price inquiry comprises obtaining a cash price response from the database;

executing the formulary alternative inquiry, wherein executing the formulary alternative inquiry comprises obtaining an alternative formulary response from the database;

inserting into the prescription inquiry response, the cash price response, and the alternative formulary response; and

transmitting the prescription inquiry response to the client device associated with the prescription inquiry.

2 . The apparatus according to claim 1 , wherein executing the formulary alternative inquiry comprises generating at least one additional prescription benefit coverage inquiry and an additional cash price inquiry based on the alternative formulary response.

3 . The apparatus according to claim 1 , wherein the computer program code, when executed by the one of more processors, further causes the one or more processors to perform:

receiving an indication of initiation of transmission of a message to at least one of a pharmacy computer or prescriber computer regarding the prescription inquiry.

4 . The apparatus according to claim 1 , wherein the cash price inquiry, the prescription benefit coverage inquiry, and the formulary alternative inquiry are in different formats that the prescription inquiry.

5 . A computer program product comprising at least one non-transitory computer-readable storage medium having computer-executable program code instructions stored therein that when executed by one or more processors, cause the one or more processors to perform:

storing, in a database, (a) a time threshold, (b) a history of prescription transactions comprising respective medications, prices, and (c) and one or more alternative treatment tables;

receiving, via a communications interface of a service provider computer, and from a client device, a prescription inquiry associated with a patient, a pharmacy, and a medication;

generating a cash price inquiry, a prescription benefit coverage inquiry, and a formulary alternative inquiry based on the prescription inquiry;

determining a claims processor computer to which to transmit the prescription benefit coverage inquiry;

transmitting the prescription benefit coverage inquiry to a pharmacy claims processor computer;

monitoring a communication network for receipt of a prescription benefit coverage response associated with the prescription benefit coverage inquiry from the claims processor computer;

determining whether a response from the pharmacy claims processor computer is received within the time threshold;

based on a determination that the response from the pharmacy claims processor computer is received within the time threshold, generating a prescription inquiry response comprising the response from the pharmacy claims processor computer;

based on a determination that the response from the pharmacy claims processor computer is not received within the time threshold, and further based on the stored history of prescription transactions, generating a prescription inquiry response that includes an estimated cost range for the medication;

executing the cash price inquiry, wherein executing the cash price inquiry comprises obtaining a cash price response from the database;

executing the formulary alternative inquiry, wherein executing the formulary alternative inquiry comprises obtaining an alternative formulary response from the database;

inserting into the prescription inquiry response, the cash price response, and the alternative formulary response; and

transmitting the prescription inquiry response to the client device associated with the prescription inquiry.

6 . The computer program product according to claim 5 , wherein executing the formulary alternative inquiry comprises generating at least one additional prescription benefit coverage inquiry and an additional cash price inquiry based on the alternative formulary response.

7 . The computer program product according to claim 5 , wherein the computer-executable program code instructions, when executed by the one or more processors, cause the one or more processors to perform:

receiving an indication of initiation of transmission of a message to at least one of a pharmacy computer or prescriber computer regarding the prescription inquiry.

8 . The computer program product according to claim 5 , wherein the cash price inquiry, the prescription benefit coverage inquiry, and the formulary alternative inquiry are in different formats that the prescription inquiry.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2021
From: HOPKINS, STACY; CROZIER, KEITH
To: MCKESSON CORPORATION
Reel/Frame 057796/0937 →
Continuity (1)
Continuation In Part 16453509 · Jun 26, 2019
References Cited (400)
US 5012035A · Sartori et al. · 1991 [cited by applicant]
US 5173851A · Off et al. · 1992 [cited by applicant]
US 5595342A · McNair et al. · 1997 [cited by applicant]
US 5628530A · Thornton · 1997 [cited by applicant]
US 5726092A · Mathews et al. · 1998 [cited by applicant]
US 5757898A · Nishikawa · 1998 [cited by applicant]
US 5769228A · Wroblewski · 1998 [cited by applicant]
US 6012035A · Freeman et al. · 2000 [cited by applicant]
US 6111218A · Akers et al. · 2000 [cited by applicant]
US 6463462B1 · Smith et al. · 2002 [cited by applicant]
US 6595342B1 · Maritzen et al. · 2003 [cited by applicant]
US 6726092B2 · Goldberg et al. · 2004 [cited by applicant]
US 6757898B1 · Ilsen et al. · 2004 [cited by applicant]
US 6769228B1 · Mahar · 2004 [cited by applicant]
US 7155397B2 · Alexander et al. · 2006 [cited by applicant]
US 7192741B2 · Otte et al. · 2007 [cited by applicant]
US 7337129B1 · Lowry et al. · 2008 [cited by applicant]
US 7346768B2 · DiRienzo · 2008 [cited by applicant]
US 7409632B1 · DiRienzo · 2008 [cited by applicant]
US 7426476B2 · Munoz et al. · 2008 [cited by applicant]
US 7734483B1 · Smith et al. · 2010 [cited by applicant]
US 7783383B2 · Eliuk et al. · 2010 [cited by applicant]
US 7840424B2 · Wiley et al. · 2010 [cited by applicant]
US 7856364B1 · Wiley et al. · 2010 [cited by applicant]
US 7912741B1 · Pinsonneault · 2011 [cited by applicant]
US 7921021B1 · Newman · 2011 [cited by applicant]
US 8036913B1 · Pinsonneault et al. · 2011 [cited by applicant]
US 8036914B1 · Pinsonneault · 2011 [cited by applicant]
US 8036918B1 · Pinsonneault · 2011 [cited by applicant]
US 8050943B1 · Wiley et al. · 2011 [cited by applicant]
US 8060379B1 · Pinsonneault et al. · 2011 [cited by applicant]
US 8126743B1 · Wilk · 2012 [cited by applicant]
US 8326773B1 · Bellamy · 2012 [cited by applicant]
US 8346571B2 · Kalies, Jr. · 2013 [cited by applicant]
US 8412537B1 · Fenton et al. · 2013 [cited by applicant]
US 8442847B1 · Shrivastava · 2013 [cited by applicant]
US 8489415B1 · Ringold · 2013 [cited by applicant]
US 8521557B1 · Ringold et al. · 2013 [cited by applicant]
US 8560340B1 · Ringold · 2013 [cited by applicant]
US 8639523B1 · Pinsonneault · 2014 [cited by applicant]
US 8645162B2 · Boerger et al. · 2014 [cited by applicant]
US 8671018B2 · Thomas et al. · 2014 [cited by applicant]
US 8712797B1 · Bezdek et al. · 2014 [cited by applicant]
US 8738399B1 · Abou Nader et al. · 2014 [cited by applicant]
US 8786650B1 · Eller et al. · 2014 [cited by applicant]
US 8799018B1 · Rea et al. · 2014 [cited by applicant]
US 8984059B2 · Johnson · 2015 [cited by applicant]
US 9026507B2 · Shraim et al. · 2015 [cited by applicant]
US 9100793B2 · Johnson · 2015 [cited by applicant]
US 9171322B2 · Spievak et al. · 2015 [cited by applicant]
US 9356947B2 · Shraim et al. · 2016 [cited by applicant]
US 9760871B1 · Pourfallah et al. · 2017 [cited by applicant]
US 9779129B1 · Lequeux · 2017 [cited by applicant]
US 9786023B2 · Cohan et al. · 2017 [cited by applicant]
US 10109027B1 · Stack · 2018 [cited by applicant]
US 10157262B1 · Pinsonneault · 2018 [cited by applicant]
US 10262383B1 · Harris, Sr. et al. · 2019 [cited by applicant]
US 10331855B1 · Bratton et al. · 2019 [cited by applicant]
US 10417380B1 · Kaye et al. · 2019 [cited by applicant]
US 10489552B2 · Pinsonneault · 2019 [cited by applicant]
US 10496793B1 · Lawrence et al. · 2019 [cited by applicant]
US 10565656B1 · Pinsonneault et al. · 2020 [cited by applicant]
US 10606984B1 · Kaye et al. · 2020 [cited by applicant]
US 10616146B1 · Hopkins et al. · 2020 [cited by applicant]
US 10628797B2 · Shraim et al. · 2020 [cited by applicant]
US 10642812B1 · Hopkins et al. · 2020 [cited by applicant]
US 10713694B1 · Harris et al. · 2020 [cited by applicant]
US 10747848B2 · Guinan · 2020 [cited by applicant]
US 10778618B2 · Karnin et al. · 2020 [cited by applicant]
US 10862832B1 · Harris · 2020 [cited by applicant]
US 10924545B2 · Momchilov et al. · 2021 [cited by applicant]
US 10924585B1 · Harris et al. · 2021 [cited by applicant]
US 10929932B1 · Golden et al. · 2021 [cited by applicant]
US 10978198B1 · Pinsonneault · 2021 [cited by applicant]
US 10999224B1 · Frechen et al. · 2021 [cited by applicant]
US 11043293B1 · Salzbrenner · 2021 [cited by applicant]
US 11170394B1 · Macinski · 2021 [cited by applicant]
US 11443835B1 · Gangaikondan-Iyer · 2022 [cited by examiner]
US 11508471B1 · Anselmi et al. · 2022 [cited by applicant]
US 11640618B1 · Burdine · 2023 [cited by applicant]
US 20010029483A1 · Schultz et al. · 2001 [cited by applicant]
US 20010034613A1 · Rubsamen · 2001 [cited by applicant]
US 20010037216A1 · Oscar et al. · 2001 [cited by applicant]
US 20010039589A1 · Aho et al. · 2001 [cited by applicant]
US 20010056359A1 · Abreu · 2001 [cited by applicant]
US 20020002495A1 · Ullman · 2002 [cited by applicant]
US 20020004812A1 · Motoyama · 2002 [cited by applicant]
US 20020032582A1 · Feeney et al. · 2002 [cited by applicant]
US 20020032583A1 · Joao · 2002 [cited by applicant]
US 20020035484A1 · McCormick · 2002 [cited by applicant]
US 20020087583A1 · Morgan et al. · 2002 [cited by applicant]
US 20020111832A1 · Judge · 2002 [cited by applicant]
US 20020133379A1 · Lewis et al. · 2002 [cited by applicant]
US 20020143579A1 · Docherty et al. · 2002 [cited by applicant]
US 20020147614A1 · Doerr et al. · 2002 [cited by applicant]
US 20020188552A1 · Kavounas et al. · 2002 [cited by applicant]
US 20020198831A1 · Patricelli et al. · 2002 [cited by applicant]
US 20030009367A1 · Morrison · 2003 [cited by applicant]
US 20030050796A1 · Baldwin · 2003 [cited by applicant]
US 20030050799A1 · Jay et al. · 2003 [cited by applicant]
US 20030069760A1 · Gelber · 2003 [cited by applicant]
US 20030074234A1 · Stasny · 2003 [cited by applicant]
US 20030097310A1 · Ono et al. · 2003 [cited by applicant]
US 20030130875A1 · Hawash et al. · 2003 [cited by applicant]
US 20030149625A1 · Leonardi et al. · 2003 [cited by applicant]
US 20030154163A1 · Phillips et al. · 2003 [cited by applicant]
US 20030172008A1 · Hage et al. · 2003 [cited by applicant]
US 20030187690A1 · Miller · 2003 [cited by applicant]
US 20030229540A1 · Algiene · 2003 [cited by applicant]
US 20030236747A1 · Sager · 2003 [cited by applicant]
US 20040006490A1 · Gingrich et al. · 2004 [cited by applicant]
US 20040039599A1 · Fralic · 2004 [cited by applicant]
US 20040054685A1 · Rahn et al. · 2004 [cited by applicant]
US 20040059607A1 · Ball et al. · 2004 [cited by applicant]
US 20040073456A1 · Gottlieb et al. · 2004 [cited by applicant]
US 20040073457A1 · Kalies · 2004 [cited by applicant]
US 20040078222A1 · Khan et al. · 2004 [cited by applicant]
US 20040078234A1 · Tallal, Jr. · 2004 [cited by applicant]
US 20040088187A1 · Chudy et al. · 2004 [cited by applicant]
US 20040103062A1 · Wood et al. · 2004 [cited by applicant]
US 20040117323A1 · Mindala · 2004 [cited by applicant]
US 20040148198A1 · Kalies · 2004 [cited by applicant]
US 20040153336A1 · Virdee et al. · 2004 [cited by applicant]
US 20040199545A1 · Wagner et al. · 2004 [cited by applicant]
US 20040236630A1 · Kost et al. · 2004 [cited by applicant]
US 20040249745A1 · Baaren · 2004 [cited by applicant]
US 20050015280A1 · Gabel et al. · 2005 [cited by applicant]
US 20050060201A1 · Connely, III et al. · 2005 [cited by applicant]
US 20050065821A1 · Kalies, Jr. · 2005 [cited by applicant]
US 20050075932A1 · Mankoff · 2005 [cited by applicant]
US 20050080692A1 · Padam et al. · 2005 [cited by applicant]
US 20050102169A1 · Wilson · 2005 [cited by applicant]
US 20050154627A1 · Zuzek et al. · 2005 [cited by applicant]
US 20050187793A1 · Myles · 2005 [cited by applicant]
US 20050197862A1 · Paterson et al. · 2005 [cited by applicant]
US 20050240442A1 · Lapsker et al. · 2005 [cited by applicant]
US 20050240473A1 · Ayers, Jr. et al. · 2005 [cited by applicant]
US 20050261939A1 · Augspurger et al. · 2005 [cited by applicant]
US 20050288972A1 · Marvin et al. · 2005 [cited by applicant]
US 20060020514A1 · Yered · 2006 [cited by applicant]
US 20060026041A1 · Ullman · 2006 [cited by applicant]
US 20060036470A1 · Oaks · 2006 [cited by applicant]
US 20060085231A1 · Brofman · 2006 [cited by applicant]
US 20060085385A1 · Foster et al. · 2006 [cited by applicant]
US 20060113376A1 · Reed et al. · 2006 [cited by applicant]
US 20060149595A1 · Williams et al. · 2006 [cited by applicant]
US 20060149784A1 · Tholl et al. · 2006 [cited by applicant]
US 20060155578A1 · Eisenberger et al. · 2006 [cited by applicant]
US 20060184391A1 · Barre et al. · 2006 [cited by applicant]
US 20060212318A1 · Dooley · 2006 [cited by applicant]
US 20060212345A1 · Soza et al. · 2006 [cited by applicant]
US 20060224414A1 · Astrup et al. · 2006 [cited by applicant]
US 20060224417A1 · Werner · 2006 [cited by applicant]
US 20060224443A1 · Soza et al. · 2006 [cited by applicant]
US 20060235747A1 · Hammond et al. · 2006 [cited by applicant]
US 20060259363A1 · Jhetam et al. · 2006 [cited by applicant]
US 20070005402A1 · Kennedy et al. · 2007 [cited by applicant]
US 20070033137A1 · Provost et al. · 2007 [cited by applicant]
US 20070043589A1 · Warren et al. · 2007 [cited by applicant]
US 20070043595A1 · Pederson · 2007 [cited by examiner]
US 20070050209A1 · Yered · 2007 [cited by applicant]
US 20070050210A1 · Wiley, II · 2007 [cited by applicant]
US 20070067186A1 · Brenner et al. · 2007 [cited by applicant]
US 20070094133A1 · Anandarao et al. · 2007 [cited by applicant]
US 20070108053A1 · Cramer et al. · 2007 [cited by applicant]
US 20070136100A1 · Daugherty et al. · 2007 [cited by applicant]
US 20070162303A1 · Wiley et al. · 2007 [cited by applicant]
US 20070168228A1 · Lawless · 2007 [cited by applicant]
US 20070185799A1 · Harrison et al. · 2007 [cited by applicant]
US 20070191985A1 · Bain · 2007 [cited by applicant]
US 20070194352A1 · Han · 2007 [cited by applicant]
US 20070202886A1 · Dhebri et al. · 2007 [cited by applicant]
US 20070204043A1 · Espinosa et al. · 2007 [cited by applicant]
US 20070219813A1 · Moore · 2007 [cited by applicant]
US 20070233525A1 · Boyle · 2007 [cited by applicant]
US 20070233526A1 · Hoffman et al. · 2007 [cited by applicant]
US 20070239493A1 · Sweetland et al. · 2007 [cited by applicant]
US 20070250341A1 · Howe et al. · 2007 [cited by applicant]
US 20070260750A1 · Feied et al. · 2007 [cited by applicant]
US 20070276697A1 · Wiley et al. · 2007 [cited by applicant]
US 20070294765A1 · Rihn et al. · 2007 [cited by applicant]
US 20070299915A1 · Shraim et al. · 2007 [cited by applicant]
US 20080033750A1 · Swiss et al. · 2008 [cited by applicant]
US 20080103836A1 · Park et al. · 2008 [cited by applicant]
US 20080112411A1 · Stafford et al. · 2008 [cited by applicant]
US 20080152107A1 · Mendiola · 2008 [cited by applicant]
US 20080183492A1 · Warren et al. · 2008 [cited by applicant]
US 20080215361A1 · Nunnari et al. · 2008 [cited by applicant]
US 20080262948A1 · Grady et al. · 2008 [cited by applicant]
US 20090006141A1 · Karr · 2009 [cited by applicant]
US 20090030719A1 · Nadas et al. · 2009 [cited by applicant]
US 20090064330A1 · Shraim et al. · 2009 [cited by applicant]
US 20090083064A1 · Mahinda · 2009 [cited by applicant]
US 20090094051A1 · Ard et al. · 2009 [cited by applicant]
US 20090100099A1 · Buckwalter · 2009 [cited by applicant]
US 20090106313A1 · Boldyga · 2009 [cited by applicant]
US 20090112707A1 · Weiss et al. · 2009 [cited by applicant]
US 20090198510A1 · Ditto · 2009 [cited by applicant]
US 20090204477A1 · Urso · 2009 [cited by applicant]
US 20090287558A1 · Seth et al. · 2009 [cited by applicant]
US 20090313112A1 · Champ et al. · 2009 [cited by applicant]
US 20090327363A1 · Cullen et al. · 2009 [cited by applicant]
US 20100030667A1 · Chudy et al. · 2010 [cited by applicant]
US 20100057640A1 · Cannata · 2010 [cited by applicant]
US 20100070298A1 · Kalies · 2010 [cited by applicant]
US 20100144259A1 · Allexon et al. · 2010 [cited by applicant]
US 20100145730A1 · Abreu · 2010 [cited by applicant]
US 20100161353A1 · Mayaud · 2010 [cited by applicant]
US 20100217622A1 · Brown et al. · 2010 [cited by applicant]
US 20100249045A1 · Babul · 2010 [cited by applicant]
US 20100285821A1 · Smeeding et al. · 2010 [cited by applicant]
US 20100287001A1 · Pearce et al. · 2010 [cited by applicant]
US 20100293236A1 · Wisner et al. · 2010 [cited by applicant]
US 20110015978A1 · Welch, Jr. · 2011 [cited by applicant]
US 20110112871A1 · Simonowski et al. · 2011 [cited by applicant]
US 20110161109A1 · Pinsonneault et al. · 2011 [cited by applicant]
US 20110196697A1 · Akers · 2011 [cited by applicant]
US 20110288886A1 · Whiddon et al. · 2011 [cited by applicant]
US 20110288925A1 · Thomas et al. · 2011 [cited by applicant]
US 20120053958A1 · Marshall et al. · 2012 [cited by applicant]
US 20120109839A1 · Anderson et al. · 2012 [cited by applicant]
US 20120136809A1 · Cannata et al. · 2012 [cited by applicant]
US 20120143627A1 · Ruben et al. · 2012 [cited by applicant]
US 20120166268A1 · Griffiths · 2012 [cited by applicant]
US 20120179481A1 · Patel et al. · 2012 [cited by applicant]
US 20120185263A1 · Emert · 2012 [cited by applicant]
US 20120185264A1 · Demogenes et al. · 2012 [cited by applicant]
US 20120253829A1 · John et al. · 2012 [cited by applicant]
US 20120253830A1 · John et al. · 2012 [cited by applicant]
US 20120253831A1 · John et al. · 2012 [cited by applicant]
US 20120253832A1 · John et al. · 2012 [cited by applicant]
US 20120253833A1 · John et al. · 2012 [cited by applicant]
US 20120253846A1 · John · 2012 [cited by examiner]
US 20120265591A1 · Hwang · 2012 [cited by applicant]
US 20120303382A1 · Paul et al. · 2012 [cited by applicant]
US 20120323608A1 · Herzlinger · 2012 [cited by applicant]
US 20130041968A1 · Cohen et al. · 2013 [cited by applicant]
US 20130046610A1 · Abraham · 2013 [cited by applicant]
US 20130103602A1 · Melnick et al. · 2013 [cited by applicant]
US 20130144715A1 · Kranzley et al. · 2013 [cited by applicant]
US 20130179180A1 · Patra · 2013 [cited by applicant]
US 20130191147A1 · Harrell · 2013 [cited by applicant]
US 20130197980A1 · Lerner et al. · 2013 [cited by applicant]
US 20130246082A1 · Brylawski et al. · 2013 [cited by applicant]
US 20130311389A1 · Kaehler et al. · 2013 [cited by applicant]
US 20140039911A1 · Iyer · 2014 [cited by examiner]
US 20140088985A1 · Grant et al. · 2014 [cited by applicant]
US 20140214435A1 · Previdi · 2014 [cited by applicant]
US 20140249861A1 · Gamble et al. · 2014 [cited by applicant]
US 20140249864A1 · Sultan et al. · 2014 [cited by applicant]
US 20140278448A1 · Sadeghi et al. · 2014 [cited by applicant]
US 20140278456A1 · Milosevich et al. · 2014 [cited by applicant]
US 20140278531A1 · Gupta · 2014 [cited by applicant]
US 20150032465A1 · Sundar et al. · 2015 [cited by applicant]
US 20150088557A1 · Huynh et al. · 2015 [cited by applicant]
US 20150142479A1 · Porter et al. · 2015 [cited by applicant]
US 20150149197A1 · Guinan · 2015 [cited by applicant]
US 20150154565A1 · Kaehler et al. · 2015 [cited by applicant]
US 20150154588A1 · Purves et al. · 2015 [cited by applicant]
US 20150195224A1 · Karnin et al. · 2015 [cited by applicant]
US 20150213195A1 · Blechman · 2015 [cited by applicant]
US 20150234991A1 · Pinsonneault · 2015 [cited by applicant]
US 20150235177A1 · Shraim et al. · 2015 [cited by applicant]
US 20150269695A1 · Pinsonneault et al. · 2015 [cited by applicant]
US 20150278472A1 · King · 2015 [cited by applicant]
US 20150332422A1 · Gilmartin · 2015 [cited by applicant]
US 20150356255A1 · Simpson et al. · 2015 [cited by applicant]
US 20150371000A1 · Pinsonneault · 2015 [cited by examiner]
US 20160012465A1 · Sharp · 2016 [cited by applicant]
US 20160103978A1 · Stong · 2016 [cited by examiner]
US 20160140593A1 · Smeeding et al. · 2016 [cited by applicant]
US 20160213512A1 · Palanker et al. · 2016 [cited by applicant]
US 20160267544A1 · Flood et al. · 2016 [cited by applicant]
US 20160267545A1 · Glass et al. · 2016 [cited by applicant]
US 20160307195A1 · Cantwell et al. · 2016 [cited by applicant]
US 20160321406A1 · Timmerman et al. · 2016 [cited by applicant]
US 20160321410A1 · Timmerman et al. · 2016 [cited by applicant]
US 20160358142A1 · Hillen · 2016 [cited by applicant]
US 20160358293A1 · Berger et al. · 2016 [cited by applicant]
US 20160359795A1 · Fehling · 2016 [cited by applicant]
US 20170034087A1 · Borenstein et al. · 2017 [cited by applicant]
US 20170039331A1 · Bezdek et al. · 2017 [cited by applicant]
US 20170220768A1 · Tanner, Jr. et al. · 2017 [cited by applicant]
US 20170255759A1 · McGrath · 2017 [cited by applicant]
US 20170323295A1 · Kranzley et al. · 2017 [cited by applicant]
US 20170324695A1 · Fischer et al. · 2017 [cited by applicant]
US 20170329922A1 · Eberting et al. · 2017 [cited by applicant]
US 20180012244A1 · Leonardi · 2018 [cited by applicant]
US 20180075212A1 · Kubey · 2018 [cited by applicant]
US 20180075215A1 · Loiacoono · 2018 [cited by applicant]
US 20180366810A1 · Nero et al. · 2018 [cited by applicant]
US 20190095582A1 · Waits · 2019 [cited by applicant]
US 20190213212A1 · Adato et al. · 2019 [cited by applicant]
US 20190252049A1 · Fotsch et al. · 2019 [cited by applicant]
US 20190348160A1 · Heavelyn · 2019 [cited by applicant]
US 20190371444A1 · Glass et al. · 2019 [cited by applicant]
US 20190385733A1 · Kaye et al. · 2019 [cited by applicant]
US 20190385734A1 · Pinsonneault · 2019 [cited by applicant]
US 20200105392A1 · Karkazis et al. · 2020 [cited by applicant]
US 20200143946A1 · Lewis · 2020 [cited by applicant]
US 20200242626A1 · Agarwal · 2020 [cited by applicant]
US 20200372988A1 · Bezdek et al. · 2020 [cited by applicant]
US 20200395114A1 · Bachwani · 2020 [cited by applicant]
US 20210217044A1 · Sigsbee · 2021 [cited by applicant]
US 20210287774A1 · Curtiss et al. · 2021 [cited by applicant]
US 20210319887A1 · Derrick, Jr. et al. · 2021 [cited by applicant]
US 20210374872A1 · Stewart et al. · 2021 [cited by applicant]
US 20210374876A1 · Cedergreen · 2021 [cited by applicant]
US 20210407642A1 · Xia et al. · 2021 [cited by applicant]
AU 2003243327A · 2003 [cited by applicant]
CA 2482370A1 · 2006 [cited by applicant]
CA 2792252A1 · 2013 [cited by applicant]
CA 2810686A1 · 2013 [cited by applicant]
CN 102362778 · 2012 [cited by applicant]
KR 100755440 · 2007 [cited by applicant]
KR 100793852 · 2008 [cited by applicant]
KR 101038074 · 2011 [cited by applicant]
KR 101101692 · 2011 [cited by applicant]
KR 20110138108 · 2011 [cited by applicant]
KR 20110138572 · 2011 [cited by applicant]
KR 101154858 · 2012 [cited by applicant]
WO WO1991006917A1 · 1991 [cited by applicant]
WO WO1995003569A2 · 1995 [cited by applicant]
WO WO1997025682A1 · 1997 [cited by applicant]
WO WO1998050871A1 · 1998 [cited by applicant]
WO WO2000039737A1 · 2000 [cited by applicant]
WO WO2003098401A2 · 2003 [cited by applicant]
WO WO2007025295A2 · 2007 [cited by applicant]
WO WO2007094772A1 · 2007 [cited by applicant]
WO WO2008092109A2 · 2008 [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 24, 2023, 2 pages, US. [cited by applicant]
American Hospital Association, “Drug Price Proposals”, dated Apr. 2019, retrieved from the Internet at <URL: https://www.aha.org/system/files/media/file/2019/04/aha-drug-policy-recommendations_2.pdf>, 8 pages. [cited by applicant]
California Health Care Foundation, “When the Price Is Not Right: State Options on Prescription Drug Pricing”, dated Jun. 2016, retrieved from the Internet at: <URL: https://www.chcf.org/wp-content/uploads/2017/12/PDF-Wh… [cited by applicant]
Hsee, Christopher K., et al., “General Evaluability Theory”, Perspectives on Psychological Science, Jul. 2010, pp. 343-355, vol. 5, No. 4, Sage Publications, Inc. on behalf of the Association for Psychological Science r… [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/867,286, dated Dec. 6, 2022, 8 pages, US. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/175,939, dated Dec. 22, 2022, 5 pages, US. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/144,426, dated Dec. 8, 2022, 21 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 16/832,318, dated Dec. 8, 2022, 26 pages, US. [cited by applicant]
Van Nuys, Ph.D., Karen, et al., “Prescription Drug Copayment Coupon Landscape”, Drug Pricing White Paper, USC Leonard D. Schaeffer Center for Health Policy and Economics, Feb. 7, 2018, retrieved from the Internet at <UR… [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/144,426, dated Mar. 21, 2024, 5 pages. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/674,366, dated Mar. 22, 2024, 6 pages. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/705,919, dated Feb. 28, 2024, 61 pages. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/175,939, dated Mar. 1, 2024, 24 pages. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Aug. 1, 2024, 3 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 19, 2024, 2 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 18/098,150, dated Aug. 27, 2024, 61 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Interview Summary received for U.S. Appl. No. 17/675,616, dated Aug. 15, 2024, 8 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/832,318, dated Jan. 28, 2022, 4 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/867,286, dated Feb. 22, 2022, 38 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/219,526, dated Feb. 3, 2022, 48 pages, U.S. [cited by applicant]
Zhu, V. et al., “Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data,” BMC Clinical Pharmacology, Jun. 22, 2012, vol. 12, No. 12., BioMed C… [cited by applicant]
Coase, R. H., “The Nature of the Firm”, Economica, Nov. 1937, pp. 386-405, vol. 4, No. 16, Blackwell Publishing for London School of Economics and Political Science, retrieved from the Internet at http://www.jstor.org/s… [cited by applicant]
Gemmill, Marin, “The price elasticity of demand for prescription drugs: An exploration of demand in different settings”, Doctor of Philosophy Thesis submitted to the London School of Economics and Political Science, Jan… [cited by applicant]
United States Patent and Trademark Office, Advisory Action and Examiner-Initiated Interview Summary received for U.S. Appl. No. 17/705,919, dated Jun. 25, 2024, 33 pages, US. [cited by applicant]
United States Patent and Trademark Office, Examiner's Answer received for U.S. Appl. No. 16/867,286, dated Jun. 28, 2024, 9 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 18, 2024, 19 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 18, 2024, 22 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/846,373, dated Jul. 25, 2024, 16 pages, US. [cited by applicant]
U.S. Appl. No. 16/816,460, “Adaptive System and Method for Adjudicating Claims to Reduce Member Responsibility”, Unpublished (Filing Date Mar. 12, 2020), (Michael Rea, Inventor), (RC Savings, LLC, Assignee). [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/816,460, dated Mar. 3, 2023, 14 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated May 19, 2023, 23 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/158,118, dated May 26, 2023, 5 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 6, 2023, 75 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Miscellaneous Office Action, Restarting Period, received for U.S. Appl. No. 17/175,939, dated Jun. 14, 2023, 23 pages, U.S. [cited by applicant]
Viswanthan, Meera, et al., “Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States,” Annals of Internal Medicine, Dec. 4, 2012, retrieved from the Internet at <http… [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/816,460, dated Aug. 10, 2023, 14 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 13, 2023, 17 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 13, 2023, 18 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/867,286, dated Sep. 19, 2023, 16 pages, US. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Oct. 19, 2023, 3 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/162,461, dated Oct. 19, 2023, 25 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/705,919, dated Aug. 17, 2023, 68 pages, US. [cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://scholar.google.com/scholar?hl=en&as_sdt=3,47&g=pharmacy+payment+benefit+copay+NDC+datab… [cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://www.google.com/search?g=pharmacy+payment+benefit+copay+ndc+database&source=int&tbs=cdr%… [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/792,413, dated Mar. 10, 2022, 4 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 17/219,526, dated Mar. 22, 2022, 11 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 16/551,962, dated Mar. 16, 2022, 10 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 17/092,705, dated Mar. 24, 2022, 9 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 16/551,962, dated Mar. 1, 2022, 14 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 5, 2024, 54 pages, US. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated Jun. 4, 2024, 38 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/867,286, dated Mar. 31, 2023, 16 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/175,939, dated Apr. 26, 2023, 24 pages, US. [cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 15/085,166, dated Jun. 15, 2022, 18 pages, U.S. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/012,565, dated Jul. 25, 2022, 43 pages, U.S. [cited by applicant]
Pharmacy Reject Codes NCPDP, 5 pages. [cited by applicant]
St. Vincent's first to use Birmingham startup's information system. The Birmingham News [Online] Apr. 11, 2005. URL: http://www.awarix.com. [cited by applicant]
St. Vincent's is Digital Flagship D. Lockridge; Birmingham Medical News [Online] Sep. 2005. [cited by applicant]
Two automatic identification technology, neither new in the sense if being recent developments . . . Patient Safety & Quality Healthcare [Online] Aug. 2005_ URL: http://www_awarix.com. [cited by applicant]
Advisory Action for U.S. Appl. No. 14/193,294 mailed Nov. 9, 2017, 3 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 11, 2019, 4 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 29, 2020, 3 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/137,371 mailed Feb. 25, 2019, 5 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/427,746 mailed Jul. 2, 2019, 2 pages. [cited by applicant]
Advisory Action received for U.S. Appl. No. 15/085,166, dated Jan. 29, 2021, 3 pages, US. [cited by applicant]
Almaro, Moshe; “Recovery and Reuse of Unused Prescription Drugs” MIT What Matters: Aug. 2005. [cited by applicant]
American Society of Health-System Pharmacists (ASHP), “Is Prescribing the Next Step in the Evolution of Pharmacy?” May 15, 2012. [cited by applicant]
Anonymous, ACS to Demonstrate Electronic Health Record Solution Suite at MMIS 2007 Conference; EHR Tools Consolidate Data, Provide Useful Information at the Point of Care for Medicaid Providers, Payers, and Patients, PR… [cited by applicant]
Anonymous, Medic; On-line Goes In-House, Chain Store Age Executive, Jan. 1987, vol. 63, Issue 1, USA; Abstract only. [cited by applicant]
Anonymous, Pharmacy Industry Leaders Launch Firm to Supply Real-Time Data, PR Newswire, Jul. 30, 2001, p. 1, New York, NY, USA. [cited by applicant]